A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity

Mutations in the epidermal growth factor receptor (EGFR) are common amongst those with non-small cell lung cancer and represent a major factor in treatment decisions, most notably in the advanced stages. Small molecule tyrosine kinase inhibitors (TKIs) that target the EGFR, such as erlotinib, gefiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chung-Shien, Sharma, Sandhya, Miao, Emily, Mensah, Cheryl, Sullivan, Kevin, Seetharamu, Nagashree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548332/
https://www.ncbi.nlm.nih.gov/pubmed/33117017
http://dx.doi.org/10.2147/LCTT.S258444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548332/
https://www.ncbi.nlm.nih.gov/pubmed/33117017
http://dx.doi.org/10.2147/LCTT.S258444

Ejemplares similares